IT7947888A0 - PREPARATION AND COMPOSITION PROCEDURE FOR THE PREVENTION AND TREATMENT OF RHEUMATOID ARTHRITIS AND SIMILAR - Google Patents

PREPARATION AND COMPOSITION PROCEDURE FOR THE PREVENTION AND TREATMENT OF RHEUMATOID ARTHRITIS AND SIMILAR

Info

Publication number
IT7947888A0
IT7947888A0 IT7947888A IT4788879A IT7947888A0 IT 7947888 A0 IT7947888 A0 IT 7947888A0 IT 7947888 A IT7947888 A IT 7947888A IT 4788879 A IT4788879 A IT 4788879A IT 7947888 A0 IT7947888 A0 IT 7947888A0
Authority
IT
Italy
Prior art keywords
prevention
preparation
treatment
similar
rheumatoid arthritis
Prior art date
Application number
IT7947888A
Other languages
Italian (it)
Other versions
IT1116524B (en
Original Assignee
Stolle Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Res & Dev filed Critical Stolle Res & Dev
Publication of IT7947888A0 publication Critical patent/IT7947888A0/en
Application granted granted Critical
Publication of IT1116524B publication Critical patent/IT1116524B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
IT47888/79A 1978-02-06 1979-02-05 PREPARATION AND COMPOSITION PROCEDURE FOR THE PREVENTION AND TREATMENT OF RHEUMATOID ARTHRITIS AND SIMILAR IT1116524B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87514078A 1978-02-06 1978-02-06

Publications (2)

Publication Number Publication Date
IT7947888A0 true IT7947888A0 (en) 1979-02-05
IT1116524B IT1116524B (en) 1986-02-10

Family

ID=25365266

Family Applications (1)

Application Number Title Priority Date Filing Date
IT47888/79A IT1116524B (en) 1978-02-06 1979-02-05 PREPARATION AND COMPOSITION PROCEDURE FOR THE PREVENTION AND TREATMENT OF RHEUMATOID ARTHRITIS AND SIMILAR

Country Status (10)

Country Link
JP (1) JPS54113425A (en)
CH (1) CH651210A5 (en)
DE (1) DE2904044C2 (en)
DK (1) DK158138C (en)
FR (1) FR2416015A1 (en)
GB (1) GB2013691B (en)
HK (1) HK30283A (en)
IT (1) IT1116524B (en)
NL (1) NL7900766A (en)
SE (1) SE448344B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732757A (en) * 1978-02-06 1988-03-22 Stolle Research And Development Corporation Prevention and treatment of rheumatoid arthritis
USRE33565E (en) * 1978-02-06 1991-04-02 Stolle Research And Development Corporation Prevention and treatment of rheumatioid arthritis
JPS58500127A (en) * 1981-02-26 1983-01-20 ユニリ−バ−　ナ−ムロ−ゼ　ベンノ−トシヤ−プ collect
ATE16349T1 (en) * 1981-04-28 1985-11-15 Stolle Res & Dev PROCESS FOR MANUFACTURE OF AN ANTI-INFLAMMATORY BOVINE MILK.
JP2561234B2 (en) * 1981-05-12 1996-12-04 スト−ル・リサ−チ・アンド・デイベロップメント・コ−ポレ−ション Anti-inflammatory agent
JPS58154513A (en) * 1982-03-09 1983-09-14 Sendai Biseibutsu Kenkyusho Preventive and remedying drug
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
DE3378890D1 (en) * 1983-06-07 1989-02-16 Stolle Res & Dev Deodorant containing bacterial antibodies
JPS6112629A (en) * 1984-06-28 1986-01-21 Lion Corp Composition for oral cavity application
DE3785033T2 (en) * 1987-07-21 1993-10-07 Stolle Res & Dev Method for obtaining immunoregulatory factors by mammalian immunization.
JP2664906B2 (en) * 1987-08-13 1997-10-22 ストール・リサーチ・アンド・デイベロップメント・コーポレーション Improved mammalian immunization
EP1171161A1 (en) * 1999-04-19 2002-01-16 Richard Weisbart Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid
JP2004525077A (en) * 2000-09-28 2004-08-19 リサーチ　コーポレイション　テクノロジーズ，インコーポレイテッド Treatment of immune-mediated diseases by oral administration of immunoglobulin G enriched plasma fraction
WO2002078741A2 (en) * 2001-01-30 2002-10-10 The Lauridsen Group, Incorporated Methods and compositions for modulating the immune system of animals
WO2002078742A2 (en) * 2001-01-30 2002-10-10 The Lauridsen Group, Incorporated Methods and compositions for treatment of immune dysfunction disorders
JP4960632B2 (en) * 2006-01-10 2012-06-27 学校法人北里研究所 Composition for treating and preventing herpes simplex virus infection comprising immune milk composition as active ingredient
JP5361132B2 (en) * 2006-03-10 2013-12-04 国立大学法人信州大学 An oral immunomodulator containing immunoglobulin G, a method for producing the same, and a food or drink comprising the oral immunomodulator
JP2008179572A (en) * 2007-01-25 2008-08-07 Shinshu Univ IMMUNOGLOBULIN Fc FRAGMENT RECEPTOR PROTEIN AND/OR PRODUCTION INHIBITOR OF IMMUNOGLOBULIN Fc FRAGMENT RECEPTOR LIKE PROTEIN, AND USE OF THE SAME

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5136326B1 (en) * 1965-10-24 1976-10-07
DE1617769A1 (en) * 1967-06-10 1971-04-01 Rehm Eberhard Process for the production of milk containing specific antibodies and preparations made therefrom
JPS5136326A (en) * 1974-09-24 1976-03-27 Komatsu Seiren Co SEIKEIGORU FUBOORU
JPS5837285B2 (en) * 1975-05-29 1983-08-15 カブシキガイシヤ ミドリジユウジ It is very difficult to understand the situation.
JPS521014A (en) * 1975-06-17 1977-01-06 Stolle Res & Dev Pharmaceutically acceptable carrier containing milk immunoglobulin
JPS5381613A (en) * 1976-12-28 1978-07-19 Green Cross Corp:The Remedies for enteral infection diseases
CH627079A5 (en) * 1977-04-15 1981-12-31 Nestle Sa Process for preparing a protein concentrate containing immunological factors of milk origin

Also Published As

Publication number Publication date
IT1116524B (en) 1986-02-10
JPS54113425A (en) 1979-09-05
HK30283A (en) 1983-09-02
SE448344B (en) 1987-02-16
FR2416015B1 (en) 1983-06-17
GB2013691A (en) 1979-08-15
DK158138B (en) 1990-04-02
JPH0160455B2 (en) 1989-12-22
DE2904044A1 (en) 1979-08-30
DE2904044C2 (en) 1986-02-06
GB2013691B (en) 1982-08-18
DK158138C (en) 1990-08-27
DK49479A (en) 1979-08-07
NL7900766A (en) 1979-08-08
CH651210A5 (en) 1985-09-13
SE7900798L (en) 1979-08-07
FR2416015A1 (en) 1979-08-31

Similar Documents

Publication Publication Date Title
IT1116524B (en) PREPARATION AND COMPOSITION PROCEDURE FOR THE PREVENTION AND TREATMENT OF RHEUMATOID ARTHRITIS AND SIMILAR
IT1113314B (en) SUMMARY PROCEDURE OF THE AMMONIA
IT1171339B (en) INHIBITING COMPOUNDS OF THE AROMATASE ENZYME AND PROCEDURE FOR THEIR PREPARATION
IT1147821B (en) COMPOSITION FOR THE TREATMENT OR PREVENTION OF INFLAMMATORY STATES OF THE INTESTINE IN MAMMALS AND PREPARATION PROCEDURE
IT8320435A0 (en) COMPOSITION FOR THE TREATMENT OF ACNE.
IT8419141A0 (en) PROCEDURE FOR THE PREPARATION OF ALPHA-L-ASPARTYL-L-PHENYLALANINE METHYL ESTER.
IT8421342A0 (en) COMPOSITIONS AND COMPOUNDS FOR THE TREATMENT OF PROSTATIC ADENOMA.
IT1096665B (en) PHARMACEUTICAL COMPOSITION FOR THE THERAPY OF FRIGIDITY AND IMPOTENCE STATES
IT1098416B (en) PROCEDURE FOR THE PRODUCTION OF BRICKS AND PLANT FOR THE IMPLEMENTATION OF THAT PROCEDURE
IT1124845B (en) METHOD FOR ADJUSTING THE HEIGHT OF CONSTRUCTION AND SIMILAR BLOCKS AND DEVICE FOR IMPLEMENTING THAT METHOD
IT1125604B (en) PROCEDURE FOR THE PREPARATION OF N-FENIL-N'-ALCHILFENILENDIAMMINE
IT8149979A0 (en) PROCEDURE FOR THE PRODUCTION OF HUMAN PARATHYROID HORMONE
IT8520463A0 (en) TREATMENT OF OSTEOPOROSIS.
IT1110294B (en) PROCEDURE FOR THE PREPARATION OF THE COLORLESS AND STABLE ISOPHONE
IT8520448A0 (en) TREATMENT OF OSTEOPOROSIS.
IT8467183A1 (en) PHARMACEUTICAL COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF ARTERIOSCLEROSIS.
IT1145433B (en) PHARMACEUTICAL COMPOSITION USABLE FOR THE TREATMENT OF HYPERTENSION
IT1148788B (en) DERIVATIVES OF THE AMINOISOKINOLINA AND PROCEDURE FOR THEIR PREPARATION
IT1122095B (en) METHOD FOR THERAPY OF RHEUMATOID ARTHRITIS AND PHARMACEUTICAL FORMULATIONS SUITABLE FOR THE PURPOSE
IT1155457B (en) PROCEDURE FOR THE PREPARATION OF OXADIAZOLIDINE DERIVATIVES
IT1147314B (en) NEW MEDICATIONS FOR THE TREATMENT OF OBESITY
IT1135094B (en) PROCEDURE FOR THE PREPARATION OF L-5-HYDROXYTYRIPHOPHANE
IT1157948B (en) PROCEDURE FOR THE PREPARATION OF ISOSORBIDE-5-NITRATE
IT1141050B (en) PROCEDURE FOR THE PREPARATION OF AMIODARONE
IT1141116B (en) PROCEDURE FOR THE PREPARATION OF AZANIDAZOLE

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19980225